Japanese musician Yoshiki, co-founder of ‘X Japan’, has donated 10 Million Yen (approx $100,000) to Japan’s National Center for Global Health and Medicine through his non-profit organization Yoshiki Foundation America. The National Centre researches infectious diseases and autoimmune diseases, including coronavirus.
Yoshiki told MetalTalk: “In America, where I live, there have been over 54,000 coronavirus deaths. It’s so sad. I heard that, unfortunately, the virus has also been spreading in Japan.
“It saddens me that people working in the entertainment industry, including myself, as well as people from many other industries, are economically and psychologically stressed because nobody knows when things will settle down. However, I believe that the people we should be supporting are the healthcare workers who are treating coronavirus patients as we speak.
“I wanted to support as much as I could. I want people, including myself, to remember that the actions of everyone who’s enduring staying home are contributing thousands of times more to the healthcare workers than what I have donated. I will also do my best as a musician to support people.”
The National Center for Global Health and Medicine tells us: “Our center aims to contribute to the health and welfare of people in Japan and all around the world through the fields of medical care, research, education, and international cooperation.
“Our mission includes the identification, assessment, prevention, diagnosis, and development of cutting-edge treatments for infectious diseases and other diseases, as well as promoting the development of medical supplies and equipment to make it possible to apply those treatments in clinical sites.
“We believe that this is exactly what YOSHIKI has been supporting. Our staff members will continue their dedicated efforts to overcome the critical situation Japan is facing today.”
In March, Yoshiki donated $100,000 to the U.S COVID-19 Relief fund. Yoshiki has also collaborated with Bono, will.i.am and Jennifer Hudson on the song ‘#SONG4LIFE’.